In This Section      
Print This Page

Johns Hopkins Medicine International Board Members

Christopher W. Kersey, M.D., M.B.A. (Chairman)

Christopher Kersey, Johns Hopkins Medicine International board member

Christopher W. Kersey, Managing Member of Camden Partners Holdings LLC, focuses on private equity investments in the health care and business services industries.  Founded in 1995, Camden Partners is one of the largest growth equity and investment management funds in the United States with more than $1 billion under management.

Dr. Kersey serves on the board of directors of Essence Group Holdings Corporation, Essia Health Inc., Implantable Provider Group (IPG) Inc., LifeNexus Corporation, Lumeris Corporation, Metabolon Inc., Paragon Bioservices Inc. and Santa Rosa Holdings Corporation (parent of Sandlot Solutions Inc.), and he serves as the Chairman of the Board of PatientSafe Solutions Inc.  Dr. Kersey’s previous portfolio companies include MedServe Inc. (acquired by Stericycle Corporation, NASDAQ: SRCL), AlgoRx Pharmaceuticals Inc. (acquired by Anesiva Corporation, NASDAQ: ANSV), LipoScience Corporation (NASDAQ: LPDX), MacroGenics Corporation (NASDAQ: MGNX), Medivance Inc. (acquired by C.R. Bard Corporation, NYSE: BCR), Pet DRx Inc. (acquired by VCA Antech Corporation, NASDAQ: WOOF), Rejuvenon Inc. (acquired by Helsinn Healthcare S.A.), Targacept Corporation (NASDAQ: TRGT), Webmedx Inc. (acquired by Nuance Communications, NASDAQ: NUAN) and Xeotron Corporation (acquired by Life Technologies Corporation, NASDAQ: LIFE).

Dr. Kersey serves as the Chairman of the Board of Johns Hopkins Medicine International, the global development arm of Johns Hopkins Medicine with hospital management and clinical education services in North America, South America, the Middle East, Europe and Asia.  Dr. Kersey serves on the board of trustees of Johns Hopkins Medicine and the board of trustees of The Johns Hopkins Hospital.  The Johns Hopkins Hospital is the only hospital in history to have earned the number one ranking for 22 years from U.S. News & World Report—an unprecedented 21 years in a row from 1991 to 2011, and again in 2013.  Dr. Kersey serves on the board of directors of The Johns Hopkins Hospital Endowment Fund, and he is a member of the Johns Hopkins Medicine Compensation Committee and the Johns Hopkins Medicine Patient Safety and Quality Committee.  Dr. Kersey also serves on The Johns Hopkins Hospital Credentials Committee.

Dr. Kersey serves on the board of directors of the Johns Hopkins Aramco Healthcare (JHAH) joint venture based in Dhahran, Saudi Arabia, one of the world's largest population health management initiatives.

Dr. Kersey’s international experience includes work with Sumitomo Biosciences in Japan and the World Bank in the former Soviet Union (the Republic of Georgia) as well as research fellowships focusing on the National Health Service in the United Kingdom and Sweden-based Telefon LM AB Ericsson's market entry into China.

A Phi Beta Kappa, Truman Scholar and Presidential Scholar graduate of Stanford University, Dr. Kersey graduated summa cum laude as the Class of 1996 Valedictorian at the Emory University School of Medicine, where he was awarded one of four Robert W. Woodruff Fellowships and elected to the Alpha Omega Alpha medical honor society.  In 1996, Dr. Kersey attained the distinction of becoming one of the first individuals in history to be accepted in the same year into the residency program of Harvard Medical School as well as Harvard Law School and Harvard Business School, where he later graduated as the Class of 1998 Walter Fellow as one of the school’s first medical doctors.

A teammate of Pete Sampras on the Prince High School All-American Tennis Team and a former professional tennis player, Dr. Kersey and his wife, the former Johannah Mayfield, have three children.